If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
CARDIOLOGY
ISSN 2054-3174 Vol 3.2 • October 2015 • emjreviews.com
INSIDE
Review of
ESC 2015
London, UK
CONTENTS
EDITORIAL BOARD......................................................................................................................................... 4
CONGRESS REVIEW........................................................................................................................................ 12
• Review of the European Society of Cardiology Congress held in London, UK,
29th August-2nd September 2015
INTERVIEWS WITH EMJ CARDIOLOGY EDITORIAL BOARD AND AUTHORS.................................. 31
SYMPOSIUM REVIEWS
• TREATMENT OF HYPERTENSION IN NEW FRONTIERS................................................................... 44
• NEW PARADIGMS IN HEART FAILURE: RAAS INHIBITION AND
CARDIOLOGY ISSN 2054-3174
CONTENTS EDITORIAL BOARD.......................
CARDIOLOGY • Diabetes and Cardiovascular Diseas
Editorial Board Editor-in-Chief: Dr Fernando A
Cardiology Prof Jawahar L. Mehta, Professor o
European Medical Journal EMJ Cardiology Vol 3.2
Welcome Greetings, and a very warm welcome to
Think Real World. Think XANTUS. The First Publish
Foreword
Available Now EMJ Cardiology 3.1 201
Editor’s Pick: State of the Art of Aortic Valve I
ESC ANNUAL CONGRESS 2015 EXCEL CENTRE, LONDON, U
Welcome to the European Medical Journal review of
ESC ANNUAL CONGRESS 2015 clearly displayed dur
H IGHLIGHTS Positive Impact of Bysta
ESC ANNUAL CONGRESS 2015 new data presented at E
“Empirical left atrial appendage isolati
ESC ANNUAL CONGRESS 2015 The new research, which
The LEADLESS II trial included 526 patients
ESC ANNUAL CONGRESS 2015 Spotlight sessions 26
“Our findings suggest that focussing resources on
ESC ANNUAL CONGRESS 2015 “Our study highlights th
syndromes. Moreover, air pollution affects
ESC ANNUAL CONGRESS 2015 The st
the association between television viewing
ESC ANNUAL CONGRESS 2015 included 386 middle
Young Adults Living in Polluted Cities May Be at
ESC ANNUAL CONGRESS 2015 on patients premature
“The association between STEMI and air pollution
HYPERKALEMIA THE THREAT IS REAL. Hyperkalemia put
INTERVIEWS Carl J. Pepine Professor of Medicine,
INTERVIEWS In past years, management of pat
have a wide variety of non-physician provid
INTERVIEWS University, and I have been there eve
could governments and healthcare providers do to
INTERVIEWS Q: One aspect of your research concer
responsible for restenosis (smooth muscle cells),
INTERVIEWS consume. As such, South Asians (
therapies for the benefit of patients – all of whi
INTERVIEWS Q: In a recent paper that you co-auth
valuable data on their disease: arrhythmia burden
INTERVIEWS Martino Pepe Interventional Cardiologi
SUBSCRIBE Follow us: FREE TO OUR YOUTUBE CHA
TREATMENT OF HYPERTENSION IN NEW FRONTIERS This s
Welcome and Introduction Professor Bryan Wi
this country where the rates of awareness (50%),
Table 1: Determinants of the burden of hypertensi
Table 2: Prevalence of risk factors in Latin Amer
algorithms for diagnosis, treatment, and fol
Clinical studies have demonstrated that
systematic analysis for the Global Burden of Dis
46. Poldermans D et al. Tolerability and bl
NEW PARADIGMS IN HEART FAILURE: RAAS INHIBITION
Current practice is to discontinue or reduce the
The main reasons for underuse of thes
Current treatment options for patients with systo
(Kayexalate®), which is neither a pleasant
The future prospects for the treatment of HF are
the AT1R. It is currently being tested in a Phase
REFERENCES 1. McMurray JJ et al; ESC Committee f
35. Healthcare Cost and Utilization Project. US A
BEST ABSTRACT AWARD WINNERS AWARD WINNERS AT
...future studies of risk factors for SAH should
BEST ABSTRACT AWARD WINNERS
ACS) compared with age and gender-matched co
ABSTRACT REVIEWS MANAGEMENT OF VERY HIGH-RI
ESC Prasugrel and ticagrelor are faster-acti
ABSTRACT REVIEWS 7. Bonello L et al. Onset
ESC Subsequently, Tang and colleagues3 s
ABSTRACT REVIEWS arteries: comparison between ac
ESC SAFETY AND EFFICACY OF DAPTOMYCIN I
ABSTRACT REVIEWS In conclusion, these results sh
ESC can be found, remains unclear. Finally, our
ABSTRACT REVIEWS DIABETES AND CARDIOVASCULAR
ESC 100 80 60 40 20 0 Blood pressure contr
ABSTRACT REVIEWS cardioprotection in a clinic
ESC compared with other ethnic groups. Asian Ind
ABSTRACT REVIEWS ENVIRONMENTAL EFFECTS ON
ESC phrased as a ‘gateway’ or ‘renorma
ABSTRACT REVIEWS with acute events leading to lo
ESC or induced pluripotent stem cells. Interesti
INTERNATIONAL, LARGE-SCALE, REAL-WORLD CL
Food and Drug Administration (FDA) and the
throughout the 1-year study period, which is of c
4.0% 3.5% 3.0% 2.5% Incidence 2.0% 1.5%
was used to identify major bleeding-rel
Safety: mortality rates The researchers observe
4. Sanna T et al. Cryptogenic stroke and underlyi
REAL-WORLD REGISTRY STUDY CONFIRMS FONDAPA
Based on these results suggesting a better benefit
angiography/angioplasty or heart surgery for any
Logistic regression was used to determine the OR
Acknowledgements Medical writing assistance was p
SELF-EXPANDING CORONARY STENTS: RATIONALE,
vascular indications and also stretches
03/02/2 0 010 15:57:04 093 (19 mm) 03/05/ 0 20
particularly applicable to the first-generation Bx
IVUS. Compared with other causes of M
vein graft interventions are examples of ea
AC Proximal
are also known to precipitate adverse cardi
Potential Self-Expanding Stent Limitations Sx st
Table 2 continued. Stent Study name Pts.
to date not being powered to address clini
coronary chronic total occlusion. Minerva Cardioa
self-expanding coronary stent with low- pressure
EUROPEAN MEDICAL JOURNAL provides influential arti
Buyer’s Guide • ACCRIVA DIAGNOSTICS • ACTELI
Cardiology • LABTECH LTD. • LEV EL DIAGNOSTI
SUBSCRIBE TO RECEIVE THE LATEST CATIONS, PUBL